Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy

By Yonemori Kan   Katsumata Noriyuki   Kaneko Masayuki   Uno Hajime   Matsumoto Koji   Kouno Tsutomu   Shimizu Chikako   Ando Masashi   Takeuchi Masahiro   Fujiwara Yasuhiro  

Breast Cancer Research and Treatment, Vol. 103, Iss. 3, 2007-07 ,pp. : 313-318

Springer Publishing Company

Access to resources Recommend Favorite

Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer

By Bertucci François  

Breast Cancer Research and Treatment, Vol. 127, Iss. 2, 2011-06 ,pp. : 363-373

Springer Publishing Company

Access to resources Recommend Favorite

Results of two randomized trials evaluating adjuvant anthracycline-based chemotherapy in 1 146 patients with early breast cancer

By Arriagada Rodrigo   Spielmann Marc   Koscielny Serge   Le Chevalier Thierry   Delozier Thierry   Rémé-Saumon Monique   Ducourtieux Muriel   Tursz Thomas   Hill Catherine  

Acta Oncologica, Vol. 44, Iss. 5, 2005-07 ,pp. : 458-466

Informa Healthcare

Access to resources Recommend Favorite

Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

By                

Oncology Letters, Vol. 9, Iss. 4, 2015-01 ,pp. : 1707-1714

Spandidos Publications

Access to resources Recommend Favorite

Early breast cancer: Adjuvant chemotherapy or radiotherapy, or both?

By Arriagada Rodrigo  

Acta Oncologica, Vol. 45, Iss. 5, 2006-07 ,pp. : 514-516

Informa Healthcare

Access to resources Recommend Favorite